receive FU 500 mg/m2 IV bolus weekly Ã—6 weeks plus leucovorin 500?mg/m2 IV weekly for 6 weeks during each 8-week cycle plus oxaliplatin 85?mg/m2 IV on weeks 1, 3, and 5 of each 8-week (FLOX) 	receive weekly intravenous infusions of oxaliplatin 40?mg/m2, 5-FU 500 mg/m2, and leucovorin 250?mg/m2 (3 weeks on, 1 week off)	progression-free survival and overall survival	11550	11756	There was no statistical significance in progression-free survival between the 2 regimens (P value by log rank test = .4619), and so was the situation in overall survival (P-value by log rank test = .5248).
